Reducing Cancer Costs Through Symptom Management and Triage Pathways.
Barkley R1, Soobader MJ2, Wang J2, Blau S3, Page RD4.https://www.ncbi.nlm.nih.gov/pubmed/30576262
Barkley R1, Soobader MJ2, Wang J2, Blau S3, Page RD4.https://www.ncbi.nlm.nih.gov/pubmed/30576262
https://www.journalofclinicalpathways.com/commentary/what-data-science-addressing-uncertainty-behind-addressing-uncertainty
https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e18098
Author: Kathy Oubre, MS https://www.ajmc.com/journals/evidence-based-oncology/2019/december-2019/empower-physicians-to-fight-financial-toxicity-with-biosimilars
Slamon DJ1, Neven P1, Chia S1, Fasching PA1, De Laurentiis M1, Im SA1, Petrakova K1, Val Bianchi G1, Esteva FJ1, Martín M1, Nusch A1, Sonke GS1, De la Cruz-Merino L1, Beck JT1, Pivot X1, Sondhi M1, Wang Y1, Chakravartty A1, Rodriguez-Lorenc K1, Taran T1, Jerusalem… Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer.
Piha-Paul SA1, Taylor MH2, Spitz D3, Schwartzberg L4, Beck JT5, Bauer TM6, Meric-Bernstam F1, Purkayastha D7, Karpiak L7, Szpakowski S8, Braiteh F9 https://www.ncbi.nlm.nih.gov/pubmed/31741715
November 19, 2019QCCA Network of 20 Oncology Practices to Integrate Population Health Analytics Solutions to Achieve Clinical and Financial Objectives Under Value-Based Care The… Quality Cancer Care Alliance Network (QCCA) Selects Integra Connect as Preferred Population Health Analytics Partner
Pietrantonio F1,2, Di Nicolantonio F3,4, Schrock AB5, Lee J6, Morano F1, Fuca G1, Nikolinakos P7, Drilon A8, Hechtman JF9, Christiansen J10, Gowen K5, Frampton GM5,… RET fusions in a small subset of advanced colorectal cancers at risk of being neglected.
Nassar AH1, Hamieh L2, Gray KP3, Thorner AR4, Fay AP5, Lasseter KD1, Abou Alaiwi S2, Nuzzo PV2, Flippot R2, Krajewski KM6, Signoretti S7, Choueiri TK2, Kwiatkowski DJ8. https://www.ncbi.nlm.nih.gov/pubmed/31653662